| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Hydroxyurea | FAERS: 11 | OFFSIDES SIDER US FAERS | |
| 2 | Minocycline | FAERS: 4 | US FAERS | |
| 3 | Teriparatide | FAERS: 4 | US FAERS | |
| 4 | Capecitabine | FAERS: 3 | US FAERS | |
| 5 | Hydroxychloroquine | FAERS: 3 | US FAERS | |
| 6 | Docetaxel | FAERS: 2 | US FAERS | |
| 7 | Doxycycline | FAERS: 2 | US FAERS | |
| 8 | Fluconazole | FAERS: 2 | US FAERS | |
| 9 | Minocycline | FAERS: 2 | US FAERS | |
| 10 | Sorafenib | FAERS: 2 | OFFSIDES US FAERS | |
| 11 | efinaconazole | FAERS: 2 | US FAERS | |
| 12 | Celecoxib | FAERS: 1 | US FAERS | |
| 13 | Diovan Hct | FAERS: 1 | US FAERS | |
| 14 | Doxycycline | FAERS: 1 | US FAERS | |
| 15 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 16 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 17 | Lenalidomide | FAERS: 1 | US FAERS | |
| 18 | Sunitinib | FAERS: 1 | US FAERS | |
| 19 | Voriconazole | FAERS: 1 | US FAERS | |
| 20 | ezogabine | FAERS: 1 | US FAERS | |
| 21 | liposomal doxorubicin | FAERS: 1 | US FAERS | |
| 22 | rucaparib | FAERS: 1 | US FAERS | |
| 23 | sofosbuvir-velpatasvir drug combination | FAERS: 1 | US FAERS | |
| 24 | Atomoxetine Hydrochloride | OFFSIDES | ||
| 25 | Darunavir | SIDER | ||
| 26 | Etoposide | SIDER | ||
| 27 | Imatinib Mesylate | OFFSIDES | ||
| 28 | Lamivudine | SIDER | ||
| 29 | Mesalamine | OFFSIDES | ||
| 30 | Mitoxantrone | SIDER | ||
| 31 | Paclitaxel | SIDER | ||
| 32 | Terbinafine | OFFSIDES | ||
| 33 | Zidovudine | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.